Matinas BioPharma Holdings, Inc.
AMEX:MTNB
0.2346 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -24.251 | -22.942 | -20.997 | -23.283 | -22.447 | -17.373 | -14.083 | -15.486 | -7.599 | -9.135 | -10.221 | -3.713 | -0.116 |
| Depreciation & Amortization
| 0.972 | 0.941 | 0.898 | 0.781 | 0.775 | 0.781 | 0.218 | 0.101 | 0.053 | 0.044 | 0.042 | 0.001 | 0 |
| Deferred Income Tax
| -0.084 | 0 | 0 | 0.002 | 0.008 | 0.006 | -0.507 | -0.357 | 0 | 0 | -1.974 | -0.326 | 0 |
| Stock Based Compensation
| 3.195 | 4.948 | 5.228 | 4.292 | 4.565 | 2.985 | 3.833 | 3.597 | 1.519 | 1.592 | 1.974 | 0.326 | 0 |
| Change In Working Capital
| -0.131 | 1.667 | -4.789 | 1.533 | -0.509 | -0.492 | 0.16 | 0.529 | -0.094 | -0.324 | 0.244 | 0.398 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.046 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.419 | -0.103 | -0.321 | 0.588 | -0.329 | 0.384 | -0.287 | 0.107 | -0.022 | -0.074 | -0.126 | 0.336 | 0 |
| Other Working Capital
| 0.288 | 1.77 | -4.468 | 0.945 | -0.179 | -0.876 | 0.447 | 0.421 | -0.072 | -0.25 | 0.37 | 0.062 | 0 |
| Other Non Cash Items
| 4.414 | 0.108 | 0.504 | 1.45 | 0.24 | 0 | 0.057 | 0.157 | 0.002 | 0.009 | 1.974 | 0.326 | 0.059 |
| Operating Cash Flow
| -15.885 | -15.278 | -19.156 | -15.223 | -17.368 | -14.092 | -10.321 | -11.459 | -6.119 | -7.814 | -7.961 | -2.988 | -0.057 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| 0 | -0.218 | -0.892 | -0.26 | -0.006 | -0.406 | -0.536 | -0.942 | 0 | -0.076 | -0.289 | -0.094 | 0 |
| Acquisitions Net
| 0 | 0 | -5.769 | -17.03 | 8.485 | 0 | 0 | 0 | 0 | 0.071 | 0 | 0 | 0 |
| Purchases Of Investments
| -8.437 | 0 | -9.481 | -23.195 | -72.106 | -5.606 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 17.645 | 13.46 | 15.25 | 40.225 | 31.445 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 5.769 | 17.03 | -8.485 | -5.606 | -535.916 | -942.18 | 0 | -5.425 | -399.614 | 0 | 0 |
| Investing Cash Flow
| 9.208 | 13.242 | 4.877 | 16.77 | -40.667 | -6.011 | -0.536 | -0.942 | 0 | -0.005 | -0.289 | -0.094 | 0 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -0.005 | -0.007 | -0.02 | -0.03 | -0.055 | -0.082 | -0.059 | -0.017 | -0.016 | -0.048 | 0 | 0 | 0 |
| Common Stock Issued
| 9.179 | 0 | 0.099 | 5.58 | 46.704 | 30.103 | 9.24 | 1.122 | 7.157 | 10 | 0 | 15.375 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.002 |
| Dividends Paid
| 0 | 0 | 0 | -843.6 | -682.8 | -2,234.43 | -587.144 | -608.343 | -4,393.809 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | 0.099 | 845.015 | 684.197 | 2,264.364 | 610.126 | 622.841 | 4,400.822 | 8.505 | 0 | -1.877 | 0.48 |
| Financing Cash Flow
| 9.174 | -0.007 | 0.079 | 6.965 | 48.047 | 29.852 | 15.867 | 15.603 | 6.997 | 8.456 | 0 | 13.498 | 0.48 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 2.497 | -2.043 | -14.2 | 8.511 | -9.988 | 9.749 | 5.01 | 3.201 | 0.878 | 0.636 | -8.25 | 10.416 | 0.422 |
| Cash At End Of Period
| 7.534 | 5.037 | 7.08 | 21.28 | 12.768 | 22.756 | 13.008 | 7.307 | 4.105 | 3.227 | 2.591 | 10.84 | 0.424 |